Brussels, 07/06/2010 (Agence Europe) - European Ombudsman Nikiforos Diamandouros has requested that the European Medicines Agency (EMA) grant access to clinical study reports and trial protocols for two anti-obesity drugs.
In 2007, researchers of a Danish research and information centre had requested access to clinical study reports and corresponding trial protocols as, they said, it is not uncommon for reporting on drug trials to be biased. The EMA had refused access arguing that...